Tevogen EPS TVGN

Diluted earnings per share by quarter and over the last twelve months, from 2022.

Tevogen's earnings per share was −$6.96 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$1.52.

Earnings per share over time

Fiscal year	EPS	Change
FY2025	−$8.79	−276%
FY2022	$5.00	n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter	Ended	EPS	On a year earlier	Last 12 months
Q2 FY26	Jun 30, 2026	−$1.52	n/a	−$6.96
Q1 FY26	Mar 31, 2026	−$1.61	n/a	−$7.15
Q4 FY25	Dec 31, 2025	−$2.33	n/a	−$8.79
Q3 FY25	Sep 30, 2025	−$1.50	n/a	n/a
Q2 FY25	Jun 30, 2025	−$1.71	n/a	n/a
Q1 FY25	Mar 31, 2025	−$3.25	n/a	n/a
Q3 FY24	Sep 30, 2024	−$1.50	n/a	n/a
Q2 FY24	Jun 30, 2024	−$2.00	n/a	n/a
Q1 FY24	Mar 31, 2024	−$13.00	n/a	n/a
Q3 FY23	Sep 30, 2023	−$1.50	−200%	−$20.00
Q2 FY23	Jun 30, 2023	−$9.00	n/a	−$17.00
Q1 FY23	Mar 31, 2023	−$13.00	n/a	−$8.00

Companies in Healthcare nearest Tevogen's size, closest first, today.

Company	EPS, 12 months	Growth
TVGNTevogen	−$6.96
NEPHNephros	$0.16	+33% a year
ATNMActinium Pharmaceuticals	$0.36
APTAlpha Pro Tech	$0.41	+24% a year
SPROSpero Therapeutics	$0.11
LFVNLifevantage	$0.40	−46% a year
ICCCImmucell	$0.08	−58% a year
KEQUKewaunee Scientific	$2.76	−33% a year
PDEXPro DEX	$4.11	+52% a year
PLXProtalix BioTherapeutics	$0.23	+283% a year
NATRNatures Sunshine Products	$1.01	+36% a year
Peer median	$0.38